ResearchMoz added Latest Research Report titled " Osteoporosis Drugs Market in BRIC Nations 2015-2019: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.

Albany, NY -- (SBWire) -- 07/06/2016 --Osteoporosis, or porous bone, is a disease characterised by low bone density and structural deterioration of bone tissue, leading to fragile bones. This increases the risk of fractures. Osteoporosis mainly affects women, but can also affect men. In women, bone loss occurs very rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement occurs too slowly. Risk factors for osteoporosis that cannot be controlled include gender, age, body size (low body weight), ethnicity, and family history. Risk factors that can be controlled include sex hormones, medication use, calcium and vitamin intake, alcohol intake, and smoking.

The osteoporosis drugs market in BRIC nations to grow at a CAGR of 17.43% over the period 2014-2019. This report covers the present scenario and the growth prospects of the osteoporosis drugs market in BRIC nations for the period 20152019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of osteoporosis. Pharmaceutical products are classified as branded and generic drugs.

Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=363332

Technavio's report, Osteoporosis Drugs Market in BRIC Nations 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Brazil, Russia, India, and China; it also covers the landscape of the osteoporosis drugs market in BRIC nations and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key countries
- Brazil
- China
- India
- Russia

Key vendors
- Amgen
- Eli Lilly
- Merck
- Novartis

Other prominent vendors
- Abiogen Pharma
- Deltanoid Pharmaceuticals
- F. Hoffmann La Roche
- GlaxoSmithKline
- IMMD
- Ligand Pharmaceuticals

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=363332

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG